How to Investigate Drug Use in Health Facilities: Selected Drug Use Indicators - EDM Research Series No. 007
(1993; 92 pages) [French] [Spanish] View the PDF document
Table of Contents
Open this folder and view contentsIntroduction
Open this folder and view contentsChapter 1: Overview
Open this folder and view contentsChapter 2: Core drug use indicators
Close this folderChapter 3: Study design and sample size
View the documentSelect the type of facilities for the study
View the documentDefine the types of prescribing encounters to be included
View the documentChoose between retrospective and prospective data
View the documentSample size
Open this folder and view contentsChapter 4: Planning and field methods
Open this folder and view contentsChapter 5: Analysis and reporting
Open this folder and view contentsChapter 6: Follow up questions
Open this folder and view contentsAnnexes
 

Select the type of facilities for the study

The first activity of an indicators study is to select the type of health facilities to be studied, drawing randomly from a larger group of such facilities. The prescribing indicators measure aspects of outpatient treatment. They are designed for use in health centers, dispensaries or hospital outpatient departments, both public and private. In general, a single drug use study would focus on one type of facility, so that the results make sense. The prescribing indicators are less useful in inpatient settings, or in specialty outpatient clinics in referral hospitals where the drug use patterns are more complex.

Table 4. Basic parameters of different types of drug use studies

 

Cross-sectional (basic)

Cross-sectional (comparative)

Supervision

Assess impact of intervention

Objective of the indicators study

To measure drug use indicators in a representative group of facilities

To compare between individual facilities or prescribers, or between groups

To identify whether a facility is above/below a set norm of practice

To assess the impact of an intervention in an intervention and a control group

# of facilities included

20

At least 10 in each group, 20 for more reliable comparisons; for individual comparisons, each facility is considered separately

Each facility sampled separately

At least 20 per group

# of prescribing encounters per facility

30

30 for comparing groups; 100 for individual facilities or prescribers

About 15 for identifying outliers with poor practices

At least 30, but depends on the need for precision

Type of prescribing data

Retrospective or prospective

Retrospective or prospective

Prospective preferred, but retrospective possible

Retrospective preferred, but depends on objectives and structure of intervention

Time frame of prescribing data

One year, if possible

One year, if possible

One day, or short period if retrospective

At least 4-6 months before and after the intervention

Type of patient care data

Prospective

Prospective

Prospective

Prospective (if necessary)

to previous section to next section
 

Last updated: May 3, 2013